The Veterinary Dermatology Drugs market is estimated to be valued at US$ 2.62 Bn or Mn in 2023 and is expected to exhibit a CAGR of 7.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Veterinary dermatology drugs are used for treating various skin diseases in pets and livestock. Some common conditions treated include bacterial and fungal infections, flea allergies, autoimmune diseases, and others. Anti-inflammatory drugs, antibiotics, antifungals, shampoos and conditioners form an important part of veterinary dermatology medication.
Market Dynamics:
Increasing pet ownership is expected to be a major growth driver for the veterinary dermatology drugs market over the forecast period. According to the APPA National Pet Owners Survey conducted in 2021, 70.6 million American households owned a pet, with 44.8% of households owning dogs and 38.4% owning cats. Proper veterinary care is important to ensure the health and wellbeing of these pets. Growing awareness about veterinary healthcare is also boosting the market growth. Additionally, increasing prevalence of pet allergies and skin diseases is propelling the demand for effective medications for treating these conditions in animals. However, high treatment costs associated with veterinary drugs may restrain the market growth.
SWOT Analysis
Strength: Veterinary dermatology drugs provides relief to animals from various skin diseases. These drugs have high efficacy and helps in healing skin issues quickly. These drugs are manufactured using high quality ingredients.
Weakness: Some veterinary dermatology drugs have side effects like gastrointestinal issues, liver damage etc on overdosing. Development of antibiotic resistant bacterial strains is also a concern. Cost of advance veterinary dermatology drugs is high.
Opportunity: Rising pet adoption and growing awareness about animal health provides growth opportunities. Untapped rural markets of developing nations offers scope for market expansion. Advance research leads to discovery of new drugs and therapies.
Threats: Stringent regulatory approvals and clinical trials delays market entry of new products. Patent expiries of blockbuster drugs impacts revenue of companies. Alternative treatment options like ayurveda and homeopathy are economically viable options.
Key Takeaways
The Global Veterinary Dermatology Drugs Market Size is expected to witness high growth, exhibiting CAGR of 7.6% over the forecast period, due to increasing pet ownership globally. Rising animal healthcare expenditure to nearly US$ 30 Bn by 2030 will boost product demand.
Regional analysis: North America dominates veterinary dermatology drugs market with a share of over 35% in 2023. Europe and Asia Pacific exhibit fast growth rates due to growing pet care industry. Japan, China, and India provide lucrative opportunities for drug makers.
Key players related content comprises: Key players operating in the Veterinary Dermatology Drugs market are Zoetis Inc., Elanco Animal Health Incorporated, Boehringer Ingelheim International GmbH, Virbac, Vetoquinol S.A., Dechra Pharmaceuticals PLC, Bayer AG, Ceva Sante Animale, Kindred Biosciences, Inc., and IDEXX Laboratories, Inc.
Read Our More Blogs : https://www.pressreleasebulletin.com/veterinary-dermatology-drugs-market-analysis-growth-forecast-outlook-2023-2030/
Sign in to leave a comment.